Ypsomed Holding AG
YPSN
Rangering i aksjer
#2948
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and... Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication companies. The company operates through three segments: Ypsomed Delivery Systems, Ypsomed Diabetes Care, and Others. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto-injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics. This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services. It markets its products through pharmaceutical partners, as well as through its own distribution network and independent distributors. It operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.
Aksjekurs
$469.39
Markedsverdi
$6.17B
Endring (1 dag)
1.63%
Endring (1 år)
18.98%
Land
CH
Handel Ypsomed Holding AG (YPSN)
Kategori
Healthcare
Antall utestående aksjer for Ypsomed Holding AG (YPSN)
Antall utestående aksjer per October 2026: 0
Ifølge Ypsomed Holding AG sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 0. Ved slutten av October 2026 hadde selskapet 0 utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Ypsomed Holding AG (YPSN) fra 2002 til 2026
Utestående aksjer ved utgangen av hvert år
| År | Utestående aksjer | Endre |
|---|---|---|
| 2025 | 13.65M | 0.00% |
| 2024 | 13.65M | 1.74% |
| 2023 | 13.42M | 5.79% |
| 2022 | 12.68M | 0.26% |
| 2021 | 12.65M | 0.07% |
| 2020 | 12.64M | 0.31% |
| 2019 | 12.60M | 0.13% |
| 2018 | 12.59M | -0.22% |
| 2017 | 12.61M | -0.09% |
| 2016 | 12.62M | 0.00% |
| 2015 | 12.62M | 0.08% |
| 2014 | 12.61M | 0.00% |
| 2013 | 12.61M | -0.31% |
| 2012 | 12.65M | -0.05% |
| 2011 | 12.66M | 5.40% |
| 2010 | 12.01M | 6.69% |
| 2009 | 11.26M | -0.08% |
| 2008 | 11.27M | 0.03% |
| 2007 | 11.26M | -0.08% |
| 2006 | 11.27M | -0.05% |
| 2005 | 11.28M | 351.15% |
| 2004 | 2.50M | -0.28% |
| 2003 | 2.51M | -77.77% |
| 2002 | 11.28M | 0.00% |
Utestående aksjer for lignende selskaper eller konkurrenter
| Selskap | Utestående aksjer | Forskjell | Land |
|---|---|---|---|
| 97.60M | - |
IE
|
|
| - | - |
CN
|
|
| - | - |
CH
|
|
| - | - |
CN
|
|
| 52.26M | - |
KR
|
